GLUE (STOCKS)
Monte Rosa Therapeutics, Inc. Common Stock
$17.750000
-0.485000 (-2.66%)
Prev close: $18.235000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Markus Warmuth
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,529.92M
- Employees
- 142
- P/E (TTM)
- -11.13
- P/B (TTM)
- 2.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.45 | $-0.39 | -0.0624 | -16.10% |
|
Dec 2025 (Q4)
|
$-0.56 | $-0.36 | -0.2014 | -56.16% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.38 | +0.0502 | +13.20% |
|
Jun 2025 (Q2)
|
$-0.15 | $-0.39 | +0.2434 | +61.87% |
Financial Statements
| Income/Loss From Continuing Operations After Tax | -$129.99M |
| Income/Loss From Continuing Operations Before Tax | -$130.76M |
| Net Income/Loss | -$129.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$129.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$129.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $736.43M |
| Current Assets | $677.55M |
| Cash | $666.20M |
| Other Current Assets | $11.35M |
| Noncurrent Assets | $58.88M |
| Fixed Assets | $28.41M |
| Other Non-current Assets | $30.47M |
| Liabilities | $214.51M |
| Current Liabilities | $71.04M |
| Accounts Payable | $7.90M |
| Wages | $5.05M |
| Other Current Liabilities | $58.09M |
| Noncurrent Liabilities | $143.48M |
| Equity | $521.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $521.92M |
| Liabilities And Equity | $736.43M |
| Comprehensive Income/Loss | -$130.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$130.93M |
| Other Comprehensive Income/Loss | -$27.98M |